Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice (Q45735077)

15 December 2017

title

Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice (English)

1 reference

Venezuelan equine encephalitis

15 December 2017

1 reference

1 reference

Venezuelan equine encephalitis virus

inferred from title

object named as

Venezuelan equine encephalitis virus

1 reference

Hart MK

1

1 reference

15 December 2017

Lind C

2

1 reference

15 December 2017

Bakken R

3

1 reference

15 December 2017

Robertson M

4

1 reference

15 December 2017

Tammariello R

5

1 reference

15 December 2017

Ludwig GV

6

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

15 December 2017

1 reference

15 December 2017

volume

20

1 reference

15 December 2017

issue

3-4

1 reference

15 December 2017

page(s)

616-622

1 reference

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

Passage of viral membrane proteins through the Golgi complex

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

Phylogenetic analysis of alphaviruses in the Venezuelan equine encephalitis complex and identification of the source of epizootic viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

Measurement of the respiratory volumes of laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900337-1

7 January 2021

10.1016/S0264-410X(01)00337-1

Identifiers

DOI

1 reference

15 December 2017

1 reference